Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual

NHS England

This public procurement record has 1 release in its history.

Award

11 Aug 2022 at 15:09

Award Notice
Summary of the contracting process

The NHS England has awarded a framework agreement for London Branded Medicines, comprising Tranche A and Annual periods. The agreement covers the period from September 1, 2022, to August 31, 2024, with possible extensions. The total contract value is £153,778,681. The procurement method employed was an open procedure above the threshold. The tender period ended on April 12, 2022. The procurement stage is classified as complete under the pharmaceutical products category.

This tender by NHS England for London Branded Medicines presents a significant business opportunity for suppliers specializing in pharmaceutical products. SMEs and large-scale suppliers in the pharmaceutical industry would find this tender suitable for fostering business growth. The framework agreement offers an extended contract duration and potential for additional periods. Businesses involved in the production, distribution, or supply of branded medicines should consider participating to expand their market presence and revenue streams.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual

Notice Description

NHS London Branded Medicines - Tranche A and Annual Offer reference number: CM/PHR/20/5614 CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5614/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-48a46094-6452-4cc9-a07d-02aa12ec6831
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/974d783d-e4b1-4113-94d0-4a6a623ae6f3
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£153,778,681 £100M-£1B
Lots Value
Not specified
Awards Value
£153,778,681 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
11 Aug 20224 years ago
Submission Deadline
12 Apr 2022Expired
Future Notice Date
Not specified
Award Date
15 Jul 20224 years ago
Contract Period
1 Sep 2022 - 31 Aug 2024 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLI London
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
28
Supplier Names

Merck Sharpe & Dohme (UK) Limited

Almirall

Vifor Pharma UK Ltd

Amgen Ltd

Abbvie Ltd

Celltrion Healthcare

Swedish Orphan Biovitrum Ltd

Ipsen

ASTRAZENECA UK LIMITED

THORNTON & ROSS LIMITED

Pfizer Ltd

GlaxoSmithKline UK Limited

Merz

Accord-UK Ltd

Teva UK Limited

Zentiva Pharma UK Ltd

Merck Serono Limited

Takeda UK Limited

AVENTIS PHARMA LIMITED t-a Sanofi

Sandoz Ltd

Eli Lilly & Company Ltd

Roche Products Ltd

Janssen-Cilag Ltd

Pharmacosmos UK Ltd

UCB Pharma Ltd

Novo Nordisk

Gedeon Richter UK Ltd

Organon Pharmaceuticals UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...